Ragon Institute
Feb 21, 2020
Alum for the Ride Darrell Irvine, PhD, Ragon Steering Committee Member and MIT Professor of Materials Science and Biological Engineering, has just published a paper in Nature Medicine showing a way to engineer an increased immune response to the vaccine adjuvant aluminum hydroxide, also known as alum, in an HIV vaccine given to […]
Jan 6, 2020
Galit Alter has published a new study in the Journal of Clinical Investigation entitled “Selective induction of antibody effector functional responses using MF59-adjuvanted vaccination.” This study is taking a new approach to determining flu vaccine efficacy, examining not the antigen, a piece of flu virus that is the main component of the vaccine, but the supporting […]
Dec 18, 2019
Ragon faculty member Musie Ghebremichael, PhD, recently published a BMC paper entitled “A comparison of machine learning techniques for classification of HIV patients with antiretroviral therapy-induced mitochondrial toxicity from those without mitochondrial toxicity.” Additional authors include Jong Lee, Elijah Paintsil, and Vivek Gopalakrishnan, of University of Massachusetts, Lowell; Yale University; and The Johns Hopkins University, […]
Dec 2, 2019
The Ragon Institute of Mass General, MIT, and Harvard received $10 million from the Bill & Melinda Gates Foundation to move towards drug-free HIV remission. HIV HIV remains a major global health challenge, with UNAIDS reporting 37.9 million people living with HIV and 1.7 million new cases each year. Antiretroviral therapy (ART) allows […]
Nov 15, 2019
New research center will help advance TB vaccine development For centuries tuberculosis (TB) has been a major global health problem and the world’s leading infectious killer. To combat this deadly disease, the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), recently announced new contract awards to establish […]
Nov 1, 2019
A new approach that targets young immune cells may also work for creating vaccines against the flu, dengue, malaria and hepatitis C October 31, 2019 LA JOLLA, CA A collaborative team of scientists has made a successful proof-of-principle demonstration of an advanced HIV vaccine strategy—an approach that may also work in protecting people from an […]
Oct 21, 2019
Scientists from the Ragon Institute of Mass General, MIT, and Harvard, led by Dr. Aaron Schmidt, Assistant Professor of Microbiology, have partnered with the Duke Human Vaccine Institute (DHVI) on a nation-wide, multidisciplinary program to develop a more universally protective influenza vaccine. The Collaborative Influenza Vaccine Innovation Centers (CIVICs) program, driven and supported by […]
Oct 4, 2019
Ragon Institute harnesses new knowledge about HIV to reinvent immunology Mary Todd Bergman | Harvard Correspondent Originally posted on The Harvard Gazette, September 19, 2019 With a promising HIV vaccine already in clinical trials, and research revealing how some people can naturally control HIV without medications, the Ragon Institute of Mass General, […]
Sep 27, 2019
Article originally published on Cell Press, Immunity, September 25, 2019 DOI:https://doi.org/10.1016/j.immuni.2019.09.001 Cambridge, MA. A team of researchers led by Dr. Daniel Lingwood from the Ragon Institute of Mass General, MIT, and Harvard have investigated how Human broadly neutralizing antibodies (bnAbs) against influenza virus can be biased for VHgene usage, suggesting gene-encoded development pathways. Sangesland et […]
Aug 5, 2019
News from the HPI Monday, 29. July 2019 Hamburg. A scientific team from the Research Department of Virus Immunology at the Heinrich Pette Institute, Leibniz Institute for Experimental Virology (HPI) has investigated the binding of NK cell receptors to HLA class II molecules. The results have now been published in the renowned journal “Nature Immunology”. […]
Jul 17, 2019
Could early treatment with antiretroviral (ARV) therapy help the body fight off HIV? Researchers affiliated with the Sub-Saharan African Network for TB/HIV Research Excellence (SANTHE) are convinced that early ARV therapy is critical to the treatment of HIV. Researchers at the University of KwaZulu-Natal (UKZN) in Durban, South Africa are conducting studies they believe […]
Jul 11, 2019
Super-charging a treatment for leukemia also makes it effective on solid tumors. Anne Trafton | MIT News Office A promising new way to treat some types of cancer is to program the patient’s own T cells to destroy the cancerous cells. This approach, termed CAR-T cell therapy, is now used to combat some types of […]
Jul 2, 2019
Ursula Brunner, a Swiss lawyer who has spent her career working for social and environmental justice, has just made a $5 million donation to the Ragon Institute to establish the Brunner Fund for Medical Discovery, Education and Social Good. This unique fund integrates medical research with social interventions that provide immediate benefit to the patients […]
Jul 1, 2019
Some of the world’s brightest young health minds will be working under the supervision of senior HIV scientists to gain insight into combating this global epidemic. KWAZULU-NATAL, South Africa — Eight students from Harvard University are currently in KwaZulu-Natal (KZN) for an intensive internship program to learn about the important HIV prevention and cure research […]
Jun 18, 2019
Team Ragon raises $64,014 for crucial services BOSTON, Mass. – On Sunday, June 2nd, 2019, more than 30 Team Ragon members, including Ragon Institute employees and their friends and family, gathered at the DCR Hatch Memorial Shell for the annual Boston AIDS Walk and 5K Run. The AIDS Walk, now in its 34th year, is […]
Jun 13, 2019
Ragon Institute-led study identifies factors contributing to placental transfer of antibodies CAMBRIDGE, Mass. – One of the most successful interventions in reducing infectious disease worldwide, vaccination still has limited effectiveness in protecting one group of patients – newborn infants. Now a study based at the Ragon Institute of Mass General, MIT, and Harvard has determined […]